Articles by Daniel Marsh
Bungie Revives Destiny 2 Vaulted Content; Sony's Investment Strategy in Focus
Bungie has started rebuilding vaulted Destiny 2 content, reversing an earlier sunsetting decision. Sony's $3.6B acquisition faces renewed scrutiny as investors await monetization details.
Moderna Surges 13% as Key Melanoma Data Looms
Moderna shares soared 13% to $174.06, touching a 52-week high, as investors await pivotal Phase 3 melanoma data due October 24.
GRAIL Soars 35% Ahead of FDA Panel, Topping All Analyst Price Targets
GRAIL shares surge 34.7% to $108.78 two days before FDA panel review of Galleri test, outpacing all analyst price targets as investors price in approval.
Oil Slump Boosts American Airlines as Fuel Costs Ease
American Airlines gained 4% as crude oil fell 3.8%, easing fuel cost concerns. Analysts remain divided with price targets ranging from $13 to $17.
UK Food Price Surge Forecast as El Niño Threatens Supply Chains
The FDF predicts UK food inflation will climb to 6.4% by July 2027, driven by El Niño and other cost pressures, testing major grocers.
Dutch Bros Shares Plunge to 52-Week Low Despite Strong Q2 Revenue Growth
Dutch Bros (BROS) shares fell to a 52-week low of $38.28 on Monday, despite Q2 revenue surging 32.5%. Analysts remain bullish, with targets implying at least 29% upside.
Nokia Rejoins EURO STOXX 50, ADR Rises 2.4%
Nokia's NYSE ADR jumped 2.4% on its EURO STOXX 50 return, though volume was light. Analysts target $15, implying 37% upside.
Oil's 4% Slide Sends Occidental Shares Lower, Testing Debt Goals
Occidental shares fell 2.5% as WTI crude dropped 4% to $92.16, near Q2 average. Analysts see 17-43% upside, but debt reduction hinges on sustained cash flow.
Novo Nordisk Shares Plunge 8% as Investors Question Post-Semaglutide Growth Strategy
Novo Nordisk ADRs dropped 8.18% to $39.705 after its capital markets day, as investors questioned how it will offset the 2032 U.S. semaglutide patent expiry. The company targets over DKK 150B in pipeline sales by 2035.
Meta Surges 9% as Wells Fargo Boosts Target Ahead of Connect
Meta shares surged 9.4% to $727.86 following a Wells Fargo target hike. All eyes turn to Meta Connect for proof of Muse's early traction.
Nutrien Shares Pare Losses as Belarus Potash Deal Lacks Key Details
Nutrien shares pared early losses after a proposed U.S.-Belarus potash deal lacked commercial terms. The stock traded at $75.52, down 2.04%.
Alphabet's Voting Shares Command 1.1% Premium Amid Search Rally
Alphabet's voting shares (GOOGL) now trade 1.15% above non-voting GOOG after a search-driven rally. Evercore's $450 target suggests 26% upside.